CBD, News, North America, Research

Former NFL star endorses Elixinol’s newest release

Leonard MarshallLeonard Marshall has found relief in Elixinol products such as the recently released Respira.

EU registered hemp seeds from Hempoint

Share this:
  •  
  •  
  •  
  •  
  •  

Respira, a new line of cannabidiol (CBD) tinctures recently released by Denver, Colorado-based Elixinol, has already proven a hit with Leonard Marshall – who knows a lot about hits.

“I suffer from anxiety, pain and headaches” said Marshall, 55, a two-time Super Bowl champion with the New York Giants during 12 years as a defensive lineman in the National Football League (NFL). “In addition to eating right and exercising, I use Respira.”

Easing symptoms of CTE

Respira can be vaped, applied topically or taken orally, and comes in grape-mint and natural flavors in dosages of either 300 mg or 600 mg of CBD oil.

Marshall was diagnosed four years ago with chronic traumatic encephalopathy (CTE), a degenerative brain condition that’s being detected in a growing number of retired NFL players. Since that time, he’s worked to raise awareness about the disease as he sought a remedy for his own often debilitating symptoms, eventually finding it in Elixinol.

“This is a product formulated for busy people like me, I can use it in my vape pen when I’m on the go,” he said of Elixinol’s new full-spectrum CBD tincture line. While Marshall prefers to vape Respira, the all-natural formulation can also be applied topically or taken orally – creating a triple option for consumers looking for the easiest way to incorporate CBD into their daily lives, said Chris Husong, Elixinol’s Director of Marketing and Sales.

Versatile, highly concentrated

“Respira is our most versatile tincture to date,” Husong said. “The customer has complete control over the delivery mechanisms.” Each 10 mg serving size of Respira – which comes in grape-mint and natural flavors – delivers high concentrations in dosages of either 300 mg or 600 mg of CBD oil.

As cannabis and CBD customers become more educated, Elixinol continues to innovate to meet changing market expectations, Husong said. Respira took more than a year of research and testing to bring to market, and was based on intensive discussions with the company’s medical advisers – physicians who bring vast anecdotal evidence about CBD’s benefits, and with customers like Marshall.

“We knew we had it right when our internal trials were overwhelmingly positive,” Husong said.

Respira is available throughout Europe and the USA.


Share this:
  •  
  •  
  •  
  •  
  •  

Get Hemp Industry Updates

* indicates required

Do you want event updates?